Stay updated on BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.
Latest updates to the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a comprehensive list of study locations across multiple regions (US states and international sites) and updated the revision tag to v3.3.3.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded a comprehensive results section with a 'Results Posted' date and detailed adverse events/outcomes across Part 1 and Part 2, including definitions for AEs/SAEs and DLTs; removed several older efficacy and PK endpoints such as ORR, DOR, PFS, TTR, Cmax, Tmax, and related PK/PD measures.SummaryDifference3%
- Check54 days agoChange DetectedRemoved the government funding/operating status notice from the page. The study details and locations remain unchanged.SummaryDifference0.2%
- Check61 days agoChange DetectedResults status updated from No Results Posted to Results Submitted for this study, indicating that trial results have been submitted.SummaryDifference0.0%
- Check75 days agoChange DetectedNo significant additions or deletions were detected; the Study Details page content and layout appear unchanged across the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check97 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%
Stay in the know with updates to BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986249 Study Alone & With Nivolumab in Solid Tumors Clinical Trial page.